Karl-Henning Kalland, M.D., Ph.D., is a Professor at the Department of Clinical Science, University of Bergen, and Senior Consultant of Virology at Haukeland University Hospital. During his Ph.D., he cloned and sequenced measles virus genes and examined transcriptional patterns in virus-infected cells, including the discovery of RNA-editing of measles virus transcripts. His postdoctoral fellowship was at Dana Farber Cancer Institute, Harvard Medical School, Boston, with discoveries of nucleocytoplasmic shuttling of the HIV-1 Rev protein and the nuclear export signal sequence in Rev. Currently, he leads a drug discovery and development program and a translational and clinical trial project of cancer immunotherapy.
Karl-Henning Kalland, M.D., Ph.D., is a Professor at the Department of Clinical Science, University of Bergen, and Senior Consultant of Virology at Haukeland University Hospital. During his Ph.D., he cloned and sequenced measles virus genes and examined transcriptional patterns in virus-infected cells, including the discovery of RNA-editing of measles virus transcripts. His postdoctoral fellowship was at Dana Farber Cancer Institute, Harvard Medical School, Boston, with discoveries of nucleocytoplasmic shuttling of the HIV-1 Rev protein and the nuclear export signal sequence in Rev. Currently, he leads a drug discovery and development program and a translational and clinical trial project of cancer immunotherapy.